Logo

American Heart Association

  40
  0


Final ID:

Fabry and HCM

  • Massera, Daniele  ( NYU Langone , NYC , New York , United States )
  • Author Disclosures:
    Daniele Massera: DO have relevant financial relationships ; Consultant:Cytokinetics:Past (completed) ; Consultant:Tenaya Therapeutics:Past (completed) ; Consultant:Rocket Pharmaceuticals:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Chiesi Pharmaceuticals:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Managing Double Trouble, How the Experts Approach Complex Cases

Friday, 11/07/2025 , 04:45PM - 05:45PM

Cardiovascular Seminar

More abstracts on this topic:
Amyloid and HCM

Rader Florian

What Makes the Fabry Heart Tick?

Jefferies John

More abstracts from these authors:
Case 3: Myocardial bridge in hypertrophic cardiomyopathy

Massera Daniele, Fearon William, Tremmel Jennifer

A Hypertrophic Cardiomyopathy-Based Model Estimate of the Prevalence of Danon Disease in the United States

Maron Martin, Massera Daniele, Manganaro Susan, Bailey Miranda, Rehbein Fletcher, Taylor Matthew

You have to be authorized to contact abstract author. Please, Login
Not Available